Free Trial
→ INSANE DRONE FOOTAGE (From Paradigm Press) (Ad)tc pixel Free UTRS Stock Alerts

Minerva Surgical (UTRS) Competitors

Minerva Surgical logo
Compare

UTRS vs. AFIB, MOTS, SSKN, DRTSW, and BDMDW

Should you buy Minerva Surgical stock or one of its competitors? Minerva Surgical's main competitors and comparable companies include Acutus Medical (AFIB), Motus GI (MOTS), Strata Skin Sciences (SSKN), Alpha Tau Medical (DRTSW), and Baird Medical Investment (BDMDW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Minerva Surgical compare to Acutus Medical?

Minerva Surgical (NASDAQ:UTRS) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, media sentiment, profitability, dividends, risk and institutional ownership.

Minerva Surgical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Minerva Surgical's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

Minerva Surgical has higher revenue and earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

56.9% of Acutus Medical shares are held by institutional investors. 8.5% of Minerva Surgical shares are held by company insiders. Comparatively, 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Acutus Medical Neutral

Minerva Surgical has a beta of 2.37, meaning that its share price is 137% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.71, meaning that its share price is 471% more volatile than the broader market.

Summary

Minerva Surgical beats Acutus Medical on 7 of the 10 factors compared between the two stocks.

How does Minerva Surgical compare to Motus GI?

Motus GI (NASDAQ:MOTS) and Minerva Surgical (NASDAQ:UTRS) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership, media sentiment and profitability.

Motus GI has a beta of 0.68, suggesting that its stock price is 32% less volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.37, suggesting that its stock price is 137% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Minerva Surgical N/A N/A N/A

Motus GI has higher earnings, but lower revenue than Minerva Surgical. Motus GI is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A

20.1% of Motus GI shares are owned by institutional investors. 0.3% of Motus GI shares are owned by insiders. Comparatively, 8.5% of Minerva Surgical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Minerva Surgical Neutral

Summary

Minerva Surgical beats Motus GI on 4 of the 7 factors compared between the two stocks.

How does Minerva Surgical compare to Strata Skin Sciences?

Minerva Surgical (NASDAQ:UTRS) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Strata Skin Sciences Neutral

32.4% of Strata Skin Sciences shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by insiders. Comparatively, 40.9% of Strata Skin Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Minerva Surgical has a beta of 2.37, indicating that its share price is 137% more volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of 0.22, indicating that its share price is 78% less volatile than the broader market.

Given Minerva Surgical's higher possible upside, research analysts clearly believe Minerva Surgical is more favorable than Strata Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Minerva Surgical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Minerva Surgical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Minerva Surgical's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Strata Skin Sciences -35.64%-476.73%-33.49%

Strata Skin Sciences has lower revenue, but higher earnings than Minerva Surgical. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A

Summary

Minerva Surgical beats Strata Skin Sciences on 7 of the 12 factors compared between the two stocks.

How does Minerva Surgical compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and Minerva Surgical (NASDAQ:UTRS) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, earnings, analyst recommendations and dividends.

In the previous week, Alpha Tau Medical had 3 more articles in the media than Minerva Surgical. MarketBeat recorded 3 mentions for Alpha Tau Medical and 0 mentions for Minerva Surgical. Alpha Tau Medical's average media sentiment score of 0.27 beat Minerva Surgical's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the media.

Company Overall Sentiment
Alpha Tau Medical Neutral
Minerva Surgical Neutral

Alpha Tau Medical has higher earnings, but lower revenue than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
Minerva Surgical N/A N/A N/A

Summary

Alpha Tau Medical beats Minerva Surgical on 2 of the 3 factors compared between the two stocks.

How does Minerva Surgical compare to Baird Medical Investment?

Minerva Surgical (NASDAQ:UTRS) and Baird Medical Investment (NASDAQ:BDMDW) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

In the previous week, Baird Medical Investment had 1 more articles in the media than Minerva Surgical. MarketBeat recorded 1 mentions for Baird Medical Investment and 0 mentions for Minerva Surgical. Baird Medical Investment's average media sentiment score of 1.79 beat Minerva Surgical's score of 0.00 indicating that Baird Medical Investment is being referred to more favorably in the news media.

Company Overall Sentiment
Minerva Surgical Neutral
Baird Medical Investment Very Positive

Baird Medical Investment has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$1.81N/A
Baird Medical Investment$24.49MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Baird Medical Investment N/A N/A N/A

Summary

Baird Medical Investment beats Minerva Surgical on 2 of the 3 factors compared between the two stocks.

Get Minerva Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UTRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UTRS vs. The Competition

Export
MetricMinerva SurgicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1K$5.58B$7.26B$13.21B
Dividend YieldN/A1.75%2.52%22.89%
P/E Ratio0.0020.86206.6619.94
Price / SalesN/A67.32562.2181.34
Price / CashN/A32.2577.1653.04
Price / BookN/A5.8610.756.03
Net Income-$34.11M$146.14M$3.50B$380.34M

Minerva Surgical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A174
AFIB
Acutus Medical
N/AN/AN/A-80.0%$3K$7.16MN/A85
MOTS
Motus GI
N/A$0.00
flat		N/AN/A$1K$319KN/A15
SSKN
Strata Skin Sciences
N/A$0.00
-98.0%		N/A-100.0%$1K$30.98MN/A114
DRTSW
Alpha Tau Medical
N/A$4.26
+5.2%		N/A+984.8%$0.00N/AN/A121

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:UTRS) was last updated on 10/14/2026 by MarketBeat.com Staff.
From Our Partners
Wall Street legend reveals his top AI stock before Oct. 20
Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...
Chaikin Analytics | Sponsoredtc pixel
Elon Musk’s One Stock Retirement Plan
Jeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...
Brownstone Research | Sponsoredtc pixel
Elon's next millionaires start October 24?
SpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...
Behind the Markets | Sponsoredtc pixel
Trump's about to unleash his Midterm Weapon
Trump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...
Monument Traders Alliance | Sponsoredtc pixel
How one AI fund pays investors every Thursday
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...
Investors Alley | Sponsoredtc pixel
INSANE DRONE FOOTAGE
New drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...
Paradigm Press | Sponsoredtc pixel
Federal Reserve Reveals Disturbing New Plan To Control Your Money
Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...
Weiss Ratings | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel